TY  - JOUR
T1  - An Overview on the Role of Surgery in Resectable Pancreatic Tumors, Literature Review
A1  - Sultan Abdullah Alomari
A1  - Ahmed Sami Alfaqihi
A1  - Khalid Abdullah Alzahrani
A1  - Khalid Hassan Alzahrani
A1  - Khalid Mohammed Alzahrani
A1  - Khalid Abdulrahman Alzahrani
A1  - Abdulrahman Ahmed Asiri
A1  - Amjad Ali Durayb
A1  - Abdulaziz Marzouq Aloatibi
A1  - Mohammed Bassam Ghandourah
A1  - Anwar Saeed Alghamdi
A1  - Mustafa Bakr Alsharif
JF  - Pharmacophore
JO  - Pharmacophore
SN  - 2229-5402
Y1  - 2021
VL  - 12
IS  - 4
DO  - 10.51847/RxWepx87LV
SP  - 86
EP  - 91
N2  - One of the most fatal cancers, making it the seventh-highest rate of cancer-related death globally is pancreatic cancer. Most individuals with pancreatic cancer are asymptomatic until the disease has progressed to an advanced stage where surgery cannot be a potentially curative intervention. The modality of treatment (especially surgery) is usually chosen based on the stage and resectability of the tumor. Provide a proper review of the effect of surgery in the resectable pancreatic cancer treatment. For articles selection the PubMed database was used, and the following keys were utilized in the mesh ((“pancreatic cancer"[Mesh]) AND (“resectable” [Mesh]) OR (“surgery"[Mesh])). To improve the rate of curative resection, patients with borderline resectable cancers can benefit from chemoradiation or preoperative (neoadjuvant) chemotherapy alone. Moreover, even in patients with resectable tumors, neoadjuvant chemotherapy has been recommended to ensure that systemic treatment is completed. Nevertheless, the only current potentially curative treatment option is surgical excision with an aggressive purpose. Depending on the location and type of tumor, a pancreatoduodenectomy, distal pancreatectomy, or complete pancreatectomy is done routinely.
UR  - https://pharmacophorejournal.com/article/an-overview-on-the-role-of-surgery-in-resectable-pancreatic-tumors-literature-review-rcupcbhoabvbfil
ER  -